Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Carl Anthony Evans currently holds 129,594 shares of CNS Pharmaceuticals, Inc. (CNSP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Carl Anthony Evans has been a net buyer of CNSP stock. They have purchased $10.0K and sold $0 worth of shares.
Carl Anthony Evans's most recent insider trade was on Apr 8, 2024, when they sold 17,500 shares at $0.00 per share.
Carl Anthony Evans serves as Executive at CNS Pharmaceuticals, Inc. (CNSP). They have executed 6 insider transactions totaling $10.0K over their tenure at the company.
Carl Anthony Evans holds the position of Executive at CNS Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 4 years and currently hold a stake valued at $0.
Carl Anthony Evans has shown a buying trading pattern, with $10.0K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Carl Anthony Evans was on Feb 1, 2024, when they purchased $10.0K worth of CNSP shares. This transaction involved 33,333 shares at $0.30 per share.
Carl Anthony Evans currently owns 129,594 shares of CNS Pharmaceuticals, Inc. (CNSP), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Carl Anthony Evans's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Carl Anthony Evans has 6 Form 4 filings on record as an insider at CNS Pharmaceuticals, Inc..
Set alerts for Carl Anthony Evans and 40,000+ other insiders.